(Q41486539)

1 October 2017

Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

Combined chemoimmunotherapy for advanced breast cancer.A comparison of BCG and levamisole (English)

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

author name string

G. N. Hortobagyi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

J. U. Gutterman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

G. R. Blumenschein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

H. Y. Yap

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

A. U. Buzdar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

C. K. Tashima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

M. A. Burgess

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

E. M. Hersh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A427716

30 June 2022

language of work or name

English

0 references

publication date

1 March 1979

1 reference

full work available at URL

1 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

1 reference

1 October 2017

43

1 reference

1 October 2017

3

1 reference

1 October 2017

1112-1122

1 reference

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 October 2017

1

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

3 May 2023

3

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

3 May 2023

4

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.

3 May 2023

6

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Immunocompetence, immunodeficiency and prognosis in cancer

3 May 2023

9

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

3 May 2023

15

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Nonparametric Estimation from Incomplete Observations

3 May 2023

16

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

Cancer Treatment Reports

19

60

963

Lichtenfeld

1976

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Letter: Levamisole and bone-marrow restoration after chemotherapy

3 May 2023

20

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Effect of postoperative radiotherapy on peripheral blood lymphocytes in patients with carcinoma of the breast

3 May 2023

21

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Levamisole in advanced human breast cancer

3 May 2023

24

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

3 May 2023

26

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

3 May 2023

28

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Levamisole in prevention of recurrent upper-respiratory-tract infections in children

3 May 2023

33

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Immunocompetence of cancer patients treated with levamisole

3 May 2023

35

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

Levamisole and neutropenia

3 May 2023

36

1 reference

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1112::AID-CNCR2820430350%3E3.0.CO;2-M

3 May 2023

Identifiers

10.1002/1097-0142(197903)43:3<1112::AID-CNCR2820430350>3.0.CO;2-M

1 reference

1 October 2017

1 reference